Microbiome Sequencing Services Market Size, Share, Growth Analysis, By Type(Amplicon, whole-genome, shotgun sequencing and others), By Application(Autoimmune disorder, cancer, gastrointestinal disorders and others), By Technology(Sequencing by synthesis, sequencing by ligation, sanger sequencing and others), By Region - Industry Forecast 2024-2031

Global Microbiome Sequencing Services Market size was valued at USD 1.39 billion in 2022 and is poised to grow from USD 1.54 billion in 2023 to USD 3.48 billion by 2031, growing at a CAGR of 10.7% in the forecast period (2024-2031).

The global market for microbiome sequencing services is poised for significant growth in the foreseeable future. The growth of the market is driven by two main factors: the increasing research on genomics-based gut studies and the rising demand for Next-generation Sequencing (NGS). The term "microbiome" refers to the collective presence of bacteria, fungi, viruses, and protists in and on the human body and the surrounding environment. To identify the microorganisms in a specific microbiome, researchers are utilizing metagenomics sequencing, a process that involves continuously sequencing genetic information from various organisms. Microbiome sequencing has gained significant attention in the scientific community due to its potential to offer advanced techniques for disease diagnosis, treatment, and prognosis. The introduction of new methodologies such as NGS and bioinformatics algorithms has led to a significant shift in clinical microbiology and infectious disease research, primarily due to the complex interactions within the microbiome. Various research institutes are developing advanced tools to enhance microbiome sequencing analysis, which will contribute to market growth in the coming years. For example, in May 2022, the Texas Biomedical Research Institute collaborated with Tulane University researchers to develop a software tool called a meta-transcriptome detector (MTD). This tool simplifies and accelerates the evaluation of genetic data related to a host and its microbiome simultaneously. It is useful for drug developers and microbiologists studying various human medical conditions such as cancer, HIV/AIDS, and malaria. Similarly, in January 2022, the Chinese Academy of Sciences supported a research team from the Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT) in creating a low-cost metagenome sequencing technology. This technology allows for high-resolution analysis of the entire range of species in a microbiome, even in samples with low biomass, damage, or contamination. The development of cost-effective solutions and the decreasing testing costs are expected to increase the adoption of microbiome sequencing services in low-income and emerging countries, thereby supporting market growth in these regions.

US Microbiome Sequencing Services Market is poised to grow at a sustainable CAGR for the next forecast year.